Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 851 - 900 out of 13,223

Document Document Title
WO/2010/104113A1
Provided is a polyhedral transition metal complex having hollow shells, the hollow shells each comprising n1 transition metal atoms (n1 is an integer of 6-60) and 2(n1) bidentate organic ligands, the bidentate organic ligands having grou...  
WO/2010/101147A1
A hydrogel forming agent comprising a substituted aromatic compound represented by general formula (I) [wherein R is a hydrogen atom or an alkyl; X is an oxygen or sulfur atom; Y1, Y2, and Y3 each is an aryl substituted by a hydrophilic ...  
WO/2009/068531A3
The present invention relates to a compound The instant invention relates to a compound of formulae (I A), (I B), (X A), (X B), (Y A) or (Y B), wherein R' represents (formula) and R' represents hydrogen, hydroxy, C1-C7alkoxy, C1-C8-alkan...  
WO/2010/099279A1
N-Alkoxyamides of 4-aminopicolinnic and-4-pyrimidinecarboxylates of formula (I) are selective herbicides for corn, canola and sugar beet.  
WO/2010/064172A3
The invention concerns compounds DLBS1425E2.2 and DLBS1425F1 isolated and identified from the extract of the plant Phaleria macrocarpa (Scheff.) Boerl. The invention also relates to the use of said compounds, either as a single active co...  
WO/2010/073126A3
Conjugate compounds comprising saccharides coupled to bioreductively activated drugs that permeate cell membranes via specific hypoxia- upregulated transporters in hypoxic cells and retain cytotoxic and rediosensitizmg activities. They a...  
WO/2010/093752A1
The invention disclosed in this document is related to the field of pesticides and their use in controlling pests. A compound having the structure (I) is disclosed.  
WO/2010/093764A1
The invention disclosed in this document is related to the field of pesticides and their use in controlling pests. A compound having the following structure is disclosed.  
WO/2010/032154A4
A ganglioside or a mixture of gangliosides, isolated from the peripheral and central nervous system of a bird, in particular a parrot, their use for the preparation of a medicament, methods for the diagnosis of Proventricular Dilatation ...  
WO/2010/088192A1
A catheter lock composition for preventing bacterial infection having an effective amount of glycerol and sodium chloride solution. The effective amount of glycerol is between about 35-60% and sodium chloride is in a concentration range ...  
WO/2010/087207A1
A low-molecular polysulfated hyaluronic acid derivative useful in the prevention and/or treatment of allergic diseases. Provided is a preventive and/or therapeutic agent for an allergic disease selected from pollinosis, allergic rhinitis...  
WO/2010/066909A3
The present invention relates in general to a compound which is characterized by a formula selected from the following formulas A, B, C, D, E or F; or a pharmaceutically acceptable salt thereof. The present invention further relates to p...  
WO/2010/082634A1
Provided are a novel compound which is retained specifically in a tumor, a method for retaining the compound in a tumor, and a method for detecting, diagnosing and treating a tumor using the same. A compound represented by formula (I) or...  
WO/2010/083537A2
Disclosed is the most optimal biomarker for the BIOLOGICAL POTENCY of Emblica Officinalis Gaertn. (AmIa) fruit and products standardized for 5% and above w/w of the said biomarker. Further, the products described herein contain from abou...  
WO/2010/081163A2
Method for selective 2-sulfation of glycosides.  
WO/2010/072754A1
The invention relates to [6)-O-α-D-Glcp→]1 →]n-6-O-β-D-Glcp-(1→-phenolic derivatives. These [6)-O-α-D-Glcp-(1→]n-6-O-β-D-Glcp-(1→-phenolic derivatives of selected phenolics are new, have a solubility in water higher than th...  
WO/2010/073126A2
Described herein are compounds that permeate cell membranes via specific hypoxia-upregulated transporters in hypoxic cells, get bioreductively activated intracellularly, and bind selectively to subcellular macromolecules to demonstrate h...  
WO/2010/071824A2
Among other things, the present disclosure provides methods for enriching, identifying, and/or quantifying unusually modified glycans (e.g., phosphorylated glycans, sulfated glycans, and/or multi-acetylated glycans). In many embodiments,...  
WO/2010/038911A4
Nobel Stevia Sweetening components are provided. Through the analysis of the components of the nobel Steviol Glycoside included in the stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correc...  
WO/2010/032154A3
A ganglioside or a mixture of gangliosides, isolated from the peripheral and central nervous system of a bird, in particular a parrot, their use for the preparation of a medicament, methods for the diagnosis of Proventricular Dilatation ...  
WO/2010/066909A2
The present invention relates in general to a compound which is characterized by a formula selected from the following formulas A, B, C, D, E or F; or a pharmaceutically acceptable salt thereof. The present invention further relates to p...  
WO/2010/067010A2
The invention relates to derivatives of morphine-6-glucuronide having formula (I) wherein R1 is a 5-membered heteroaromatic group optionally substituted by one or more substituents selected from among halogen atoms and (C1-C4)alkyl, halo...  
WO/2010/067008A2
The invention relates to compounds having formula (I) wherein: R1 represents a hydrogen atom or a (C1-C4)alkyl group; R2 represents a hydroxyl group, a thiol group, a (C1-C4)alkyloxy group or a thio(C1-C4)alkyl group; and n is an integer...  
WO/2010/067007A2
The invention relates to a method for preparing morphine-6-glucuronide or one of the derivatives thereof, comprising the following steps: (i) reacting a compound having formula (I), wherein R1 represents a carbonyl group, COR5CO or S02R6...  
WO/2009/095588A3
The invention relates to compounds of the formula (I) in which: R1 = OH or NH2; OR2, OR3, OR4 and OR5 form alcohol, ether, ester, carbonate, carbamate, sulphonate or sulphamate functions; and if R5 = H, if R2 =R3=R4, then R2, R3 and R4 ...  
WO/2010/062197A1
Processes for obtaining a ganglioside-enriched extract or one or more gangliosides from a ganglioside-containing lipid composition (GCLC) are disclosed. The processes comprise: (a) mixing a GCLC with one or more C4-C10 alcohols and water...  
WO/2010/058130A1
The invention relates to the methyl pentasaccharide O-2,3,4-tri-O-methyl-α-D-glucopyranosyl-(1 →4)-O-2,3-di-O-methyl-β-D-glucopyranosyluronic acid-(1 →4)-O-α-D-glucopyranosyl-(1 →4)-O-2,3-di-O-méthyl-α-L-idopyranosyluronic aci...  
WO/2010/055898A1
An n-type semiconductor composed of a fullerene compound represented by formula (1), which can provide an n-type semiconductor material which is soluble in an organic solvent and capable of providing a uniform thin film. (In the formula,...  
WO/2010/030704A3
Compounds having antibacterial activity are disclosed. The compounds have the following structure (I) including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, Z1, Z2, Z3, Z4, R1, R2 and R3 are as d...  
WO/2009/153434A3
The present invention relates to novel synthetic analogues of phosphatidyl-myo-inositol mannosides (hereinafter referred to as PIMs) of general formula (I): or a pharmaceutically acceptable salt thereof, to the method for preparing same ...  
WO/2010/049751A1
The invention relates to lipochitooligosaccharides obtainable from arbuscular mycorrhizal fungi, and which are useful for stimulating arbuscular mycorrhizal symbiosis, and lateral root formation.  
WO/2010/050413A1
Provided is an efficient method for producing a glycolipid biosurfactant, particularly a lactonic sophorose lipid at a low cost, wherein the method includes culturing a microorganism which produces the biosurfactant by limiting oxygen su...  
WO/2009/139719A9
The present invention relates to novel synthesis routes for preparation of thiodigalactosides of the general formula (12). The method comprises the use of a 3-azido-galactosyl thiouronium salt derivative, which is activated to the corres...  
WO/2010/018474A3
The invention relates to a novel ester, the 3,5-di-tertiobutyl-4-hydroxybenzoate of 3,4,5-trihydroxy-6-methoxytetrahydropyran-2-yl methyl defined by the following formula (I). The invention also relates to the method for preparing the co...  
WO/2010/014814A3
The present invention discloses a set of glycosylated warfarin analogs which are useful as anti-tumor or anti-metastatic agents and as reagents for studying sugar uptake in cells.  
WO/2009/150022A3
The invention relates to the enzymatic synthesis of sphingolipids and compositions that contain sphingolipids from lysosphingolipids and carbonic esters, and to cosmetic, dermatological or pharmaceutical formulations containing said sphi...  
WO/2009/150023A3
The invention relates to the enzymatic synthesis of sphingolipids and compositions that contain sphingolipids from lysosphingolipids and carbonic esters, and to cosmetic, dermatological or pharmaceutical formulations containing said sphi...  
WO/2010/043049A1
The invention relates to improvements in the field of drug delivery. More particularly, the invention relates to polypeptides having a hydrolyzable covalent bond to a therapeutic agent that includes, etoposide, etoposide 4'- dimethylglyc...  
WO/2010/042851A1
Compounds having antibacterial activity are disclosed. The compounds have the following structure (I): (I) including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, R1, R2 and R3 are as defined here...  
WO/2010/042850A1
Compounds having antibacterial activity are disclosed. The compounds have the following structure (I):(I) including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, R1, R2 and R3 are as defined herei...  
WO/2010/041746A1
Disclosed is a Helicobacter pylori bacterium proliferation inhibitor which comprises a compound capable of inhibiting the proliferation of a Helicobacter pylori bacterium specifically, does not produce any bacterium that is resistant to ...  
WO/2010/037179A1
The invention relates to anionic conjugates of glycosylated bacterial metabolites that may be used to mimic the structure and/or activity of the anionic bioactive molecules known as glycosaminoglycans (GAGs). The invention also relates t...  
WO/2010/039159A1
A crystalline form of epirubicin hydrochloride, named herein as 'type II' crystalline epirubicin hydrochloride, has excellent thermal stability. Type II crystalline epirubicin hydrochloride has a powder X-ray diffraction pattern having a...  
WO/2010/004433A3
Hydrophobically enhanced aminoglycosides have been prepared and shown to be effective antibacterial agents. These agents may be used in the treatment or prevention of various bacterial infections. Methods of preparing these agents also p...  
WO/2010/037180A1
The invention relates to anionic oligosaccharide conjugates that may be used to mimic the structure and/or activity of the anionic bioactive molecules known as glycosaminoglycans (GAGs).  
WO/2010/038911A1
Nobel Stevia Sweetening components are provided. Through the analysis of the components of the nobel Steviol Glycoside included in the stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correc...  
WO/2010/032154A2
A ganglioside or a mixture of gangliosides, isolated from the peripheral and central nervous system of a bird, in particular a parrot, their use for the preparation of a medicament, methods for the diagnosis of Proventricular Dilatation ...  
WO/2010/030690A1
The present invention is directed to aminoglycoside compounds of general formula (I) as well as their preparation and use as prophylactic or therapeutics against microbial infection.  
WO/2010/030012A1
Disclosed are a novel esterified α-galactosylceramide which is effective for the treatment of cancer or the like, and a pharmaceutical preparation comprising the esterified α-galactosylceramide. Specifically disclosed is a compound rep...  
WO/2010/029185A1
A compound of the following formula or a salt, solvate or formula (I) and a pharmaceutical composition containing said compound. It concerns also its use in the treatment of cancer and/or of pathological angiogenesis and/or in promoting ...  

Matches 851 - 900 out of 13,223